期刊
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
卷 34, 期 1, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.berh.2019.101474
关键词
Raynaud's phenomenon; Connective tissue disease; Systemic sclerosis; Pathogenesis; Autoantibodies; Capillaroscopy; Treatment
类别
资金
- NIHR Manchester Biomedical Research Centre
- Martha McCrory Endowed Professorship
Raynaud's phenomenon (RP) is common, affecting approximately 5% of the population, and is important to the rheumatologist because it is often the presenting symptom of connective tissue disease, especially of systemic sclerosis (SSc)-spectrum disorders. RP therefore provides a window of opportunity for early diagnosis. When RP is associated with SSc it is particularly challenging to treat. This review begins with a discussion of some of the recent advances in our understanding of the pathogenesis of RP: it is through increased understanding of the complex pathophysiology of RP that we are most likely to develop new therapies. The following questions are then addressed (with three clinical scenarios demonstrating key principles of assessment and management): 1. How can we predict underlying connective tissue disease in the patient presenting with Raynaud's? 2. How can we measure severity of Raynaud's? 3. What are the latest advances in treatment of connective tissue disease-related digital vasculopathy? (C) 2019 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据